RENO, Nev., Oct. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- China Food and Beverage Company (OTC:CHIF), announced today that its healthcare division in cooperation with Shanghai based, American Medical Care and Insurance (AMC Shanghai) has launched an Artificial Intelligence (AI) software program based on a Traditional Chinese Medicine Clinical Decision Support System (TCM CDSS). The system is an AI assisted diagnosis and treatment cloud platform. In addition, the system integrates various functions such as centralized medical research, analysis and statistics, quantitative calculation, chart analysis, intelligent auxiliary diagnosis, medical record interpretation, and prescription matching. The TCM CDSS Cloud Platform is part of the Company's continued commitment to transform healthcare in China and around the globe. Among the goals of the platform are to keep patients out of hospitals, early detection of life threatening diseases and major clinical research studies of diseases such as diabetes and cardio vascular disease, both of which have reached the epidemic stage in the world's largest country.